07:00 , Sep 29, 2014 |  BC Week In Review  |  Financial News

Tracon completes venture financing

Tracon Pharmaceuticals Inc. , San Diego, Calif.   Business: Cancer   Date completed: 2014-09-22   Type: Venture financing   Raised: $27 million   Investors: New Enterprise Associates; BioMed Venture; institutional investor; JAFCO; Nextech Invest; Brookline...
03:09 , Sep 23, 2014 |  BC Extra  |  Financial News

Tracon raises $27M in B round

Tracon Pharmaceuticals Inc. (San Diego, Calif.) raised $27 million in a series B round led by New Enterprise Associates. Additional new investors included BioMed Ventures and an undisclosed institutional investor. Existing investors JAFCO; Nextech Invest;...
07:00 , Apr 25, 2011 |  BC Week In Review  |  Financial News

Tracon completes venture financing

Tracon Pharmaceuticals Inc. , San Diego, Calif.   Business: Cancer   Date completed: 4/20/11   Type: Venture financing   Raised: $14 million   Investors: JAFCO; Nextech Invest; Arcus Ventures; BHP; Brookline Investments   Note: The...
08:00 , Jan 9, 2004 |  BC Extra  |  Politics & Policy

FDA dietary supplement authority upheld

The United States Court of Appeals for the District of Columbia Circuit today upheld FDA's authority to classify health claims on dietary supplement labels as drug claims. The ruling allows FDA to hold supplement manufacturers...
07:00 , Jul 11, 2002 |  BC Extra  |  Company News

Synaptic, Ranbaxy urology deal

SNAP granted Ranbaxy (New Delhi, India) a non-exclusive license to its technology for selectively antagonizing alpha-1a receptors to treat benign prostatic hyperplasia (BHP). SNAP will receive an up-front licensing fee, and is eligible for milestones...